Martin Osterhout
Bayer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Martin Osterhout.
Bioorganic & Medicinal Chemistry Letters | 2001
Aniko Redman; Jeffrey S Johnson; Robert Dally; Steve Swartz; Hanno Wild; Holger Paulsen; Yolanda V Caringal; David E. Gunn; Joel Renick; Martin Osterhout; Jill Kingery-Wood; Roger A. Smith; Wendy Lee; Jacques Dumas; Scott Wilhelm; Timothy J Housley; Ajay Bhargava; Gerald Ranges; Alka Shrikhande; Deborah Young; Michael Bombara; William J. Scott
Inhibitors of the MAP kinase p38 are potentially useful for the treatment for osteoporosis, arthritis, and other inflammatory diseases. A series of thienyl, furyl, and pyrrolyl ureas has been identified as potent p38 inhibitors, displaying in vitro activity in the nanomolar range.
Bioorganic & Medicinal Chemistry Letters | 2002
Jacques Dumas; Holia Hatoum-Mokdad; Robert Sibley; Roger A. Smith; William J. Scott; Uday Khire; Wendy Lee; Jill E. Wood; Donald John Wolanin; Jeffrey Cooley; Donald Bankston; Aniko Redman; Robert W. Schoenleber; Yolanda V Caringal; David E. Gunn; Romulo Romero; Martin Osterhout; Holger Paulsen; Timothy J Housley; Scott Wilhelm; John Pirro; Du-Shieng Chien; Gerald Ranges; Alka Shrikhande; Andrew Muzsi; Elizabeth Bortolon; Jean Wakefield; Cynthia Gianpaolo Ostravage; Ajay Bhargava; Thuy Chau
Inhibitors of the MAP kinase p38 provide a novel approach for the treatment of osteoporosis, inflammatory disorders, and cancer. We have identified N-(3-tert-butyl-1-methyl-5-pyrazolyl)-N-(4-(4-pyridinylmethyl)phenyl)urea as a potent and selective p38 kinase inhibitor in biochemical and cellular assays. This compound is orally active in two acute models of cytokine release (TNF-induced IL-6 and LPS-induced TNF) and a chronic model of arthritis (20-day murine collagen-induced arthritis).
Bioorganic & Medicinal Chemistry Letters | 2002
Roger A. Smith; Donald L. Hertzog; Martin Osterhout; Gaetan Ladouceur; Mary Korpusik; Mark Bobko; J.Howard Jones; Kathleen M. Phelan; Romulo Romero; Thomas Hundertmark; Margit MacDougall; James N. Livingston; William R. Schoen
A narrow structure-activity relationship was established for the 4-aryl group in 4-aryl-pyridine glucagon antagonists, with only small substituents being well-tolerated, and only at the 3- and 4-positions. However, substitution with a 2-hydroxy group gave a ca. 3-fold increase in activity (e.g., 4-fluoro-2-hydroxy analogue 33, IC50=190 nM). For efficient preparation of 2-substituted phenylpyridines, a novel synthesis via pyrones and 4-methoxy-pyridines was developed.
Bioorganic & Medicinal Chemistry Letters | 2002
Gaetan Ladouceur; James H. Cook; Donald L. Hertzog; J.Howard Jones; Thomas Hundertmark; Mary Korpusik; Timothy G. Lease; James N. Livingston; Margit MacDougall; Martin Osterhout; Kathleen M. Phelan; Romulo Romero; William R. Schoen; Chunning Shao; Roger A. Smith
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1R)-hydroxyethyl] and a 2-hydroxy group. Due to restricted rotation of the phenyl-pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC(50)=10-25 nM.
Archive | 1998
Scott Miller; Martin Osterhout; Jacques Dumas; Uday Khire; Timothy B. Lowinger; William J. Scott; Roger A. Smith; Jill E. Wood; David E. Gunn; Holia Hatoum-Mokdad; Marell Rodriguez; Robert Sibley; Ming Wang; Tiffany Turner; Catherine Brennan
Archive | 1998
Scott Miller; Martin Osterhout; Jacques Dumas; Uday Khire; Timothy B. Lowinger; Bernd Riedl; William J. Scott; Roger A. Smith; Jill E. Wood; David E. Gunn; Ming Wang; Tiffany Turner; Catherine Brennan
Archive | 1997
Gunter Schmidt; Rolf Angerbauer; Arndt Brandes; Matthias Dr. Müller-Gliemann; Hilmar Bischoff; Delf Schmidt; Stefan Wohlfeil; William R. Schoen; Gaetan Ladouceur; James H. Cook; Timothy G. Lease; Donald John Wolanin; Richard H. Kramss; Donald L. Hertzog; Martin Osterhout
Archive | 1998
Richard Connell; Timothy G. Lease; Gaetan Ladouceur; Martin Osterhout
Archive | 1998
Richard Connell; Timothy G. Lease; Gaetan Ladouceur; Martin Osterhout
Archive | 1998
Scott Miller; Martin Osterhout; Jacques Dumas; Uday Khire; Bruno Lowinger; Bernd Riedl; J Scott; A Smith; E Wood; David E. Gunn; Holia Hatoum-Mokdad; Robert Sibley; Ming Wang; Tiffany Turner; Catherine Brennan